JP2004131466A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004131466A5 JP2004131466A5 JP2003158552A JP2003158552A JP2004131466A5 JP 2004131466 A5 JP2004131466 A5 JP 2004131466A5 JP 2003158552 A JP2003158552 A JP 2003158552A JP 2003158552 A JP2003158552 A JP 2003158552A JP 2004131466 A5 JP2004131466 A5 JP 2004131466A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- compound
- flaviviridae
- compound according
- infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 description 40
- 239000003446 ligand Substances 0.000 description 19
- 241000710781 Flaviviridae Species 0.000 description 18
- 208000015181 infectious disease Diseases 0.000 description 9
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 8
- 229960000329 ribavirin Drugs 0.000 description 8
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 8
- 241000700605 Viruses Species 0.000 description 7
- 125000004430 oxygen atom Chemical group O* 0.000 description 7
- 241000725619 Dengue virus Species 0.000 description 6
- 241000711549 Hepacivirus C Species 0.000 description 6
- 241000710842 Japanese encephalitis virus Species 0.000 description 6
- 241000710888 St. Louis encephalitis virus Species 0.000 description 6
- 241000710886 West Nile virus Species 0.000 description 6
- 241000710772 Yellow fever virus Species 0.000 description 6
- 229910052717 sulfur Inorganic materials 0.000 description 6
- 125000004434 sulfur atom Chemical group 0.000 description 6
- 229940051021 yellow-fever virus Drugs 0.000 description 6
- 102000006992 Interferon-alpha Human genes 0.000 description 5
- 108010047761 Interferon-alpha Proteins 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38503102P | 2002-06-03 | 2002-06-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004131466A JP2004131466A (ja) | 2004-04-30 |
| JP2004131466A5 true JP2004131466A5 (https=) | 2006-07-20 |
Family
ID=29550193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003158552A Pending JP2004131466A (ja) | 2002-06-03 | 2003-06-03 | フラビウイルス感染症の治療 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1369120B1 (https=) |
| JP (1) | JP2004131466A (https=) |
| KR (1) | KR20030094097A (https=) |
| CN (1) | CN1251687C (https=) |
| AT (1) | ATE353658T1 (https=) |
| DE (1) | DE60311702T2 (https=) |
| TW (1) | TWI274585B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20090058423A (ko) * | 2007-12-04 | 2009-06-09 | 심형섭 | 소디움 메타아르세나이트를 함유하는 ｃ형 바이러스성 간염치료용 조성물 |
| RU2518314C2 (ru) * | 2012-08-30 | 2014-06-10 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Способ и средство активации irf-3 для лечения и профилактики заболеваний, вызываемых (+) phk-содержащими вирусами |
| TWI605822B (zh) * | 2015-04-09 | 2017-11-21 | 高雄醫學大學 | 酪梨萃取物、ａｖｏｃａｄｅｎｏｌ Ｂ及（２Ｒ，４Ｒ）－１，２，４－三羥基十七碳－１６－炔的用途，以及包含酪梨萃取物之保健食品 |
| EP3815699A1 (en) * | 2019-10-28 | 2021-05-05 | Technische Universität München | New means and methods for therapy and diagnosis of adenoviral infection |
| IL295648A (en) * | 2020-02-16 | 2022-10-01 | Komipharm Int Australia Pty Ltd | treatment method |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9214419D0 (en) * | 1992-07-07 | 1992-08-19 | Concannon Peter | Biocidal agents |
| JPH0769903A (ja) * | 1993-07-01 | 1995-03-14 | Hatsuchiyou:Kk | 抗ヒト免疫不全ウイルス剤およびエイズ治療薬 |
| WO1995011033A1 (en) * | 1993-10-22 | 1995-04-27 | Commonwealth Scientific And Industrial Research Organisation | Polyoxometallates in the treatment of flavivirus infections |
| FR2786103A1 (fr) * | 1998-10-30 | 2000-05-26 | Assist Publ Hopitaux De Paris | Utilisation de trioxyde d'arsenic pour la preparation d'un medicament destine a traiter les affections neoplastiques du tissu hematopoietique chez un mammifere et nouvelle composition pharmaceutique |
| JP4420997B2 (ja) * | 1999-02-08 | 2010-02-24 | 利博 山瀬 | 抗ウィルス剤 |
| AU4463300A (en) * | 1999-04-19 | 2000-11-02 | Schering Corporation | Hcv combination therapy, containing ribavirin in association with antioxidants |
| JP2001233719A (ja) * | 1999-12-13 | 2001-08-28 | Natl Inst Of Advanced Industrial Science & Technology Meti | 殺菌材および殺菌方法 |
| WO2001049302A1 (en) * | 2000-01-06 | 2001-07-12 | Marantech Holding, Llc | Compositions and methods for facilitating skin growth and managing skin conditions |
| US7744867B2 (en) * | 2001-05-31 | 2010-06-29 | The Cleveland Clinic Foundation | PTPase inhibitors and method of using same |
-
2003
- 2003-06-02 AT AT03012517T patent/ATE353658T1/de not_active IP Right Cessation
- 2003-06-02 EP EP03012517A patent/EP1369120B1/en not_active Expired - Lifetime
- 2003-06-02 TW TW092114876A patent/TWI274585B/zh not_active IP Right Cessation
- 2003-06-02 DE DE60311702T patent/DE60311702T2/de not_active Expired - Lifetime
- 2003-06-03 JP JP2003158552A patent/JP2004131466A/ja active Pending
- 2003-06-03 KR KR10-2003-0035627A patent/KR20030094097A/ko not_active Withdrawn
- 2003-06-03 CN CNB031386946A patent/CN1251687C/zh not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011528713A5 (https=) | ||
| JP2009511595A5 (https=) | ||
| JP2013507439A5 (https=) | ||
| WO2005037860A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| WO2005077969A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| JP2014530874A5 (https=) | ||
| SE0102764D0 (sv) | Compounds | |
| JP2005530743A5 (https=) | ||
| EP2039686A4 (en) | DIHYDROPYRIMIDIN COMPOUNDS AND THEIR USES IN THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT AND PREVENTION OF ANTIVIRAL DISEASES | |
| WO2006050250A3 (en) | Dose forms comprising vx-950 and their dosage regimen | |
| JP2010539241A5 (https=) | ||
| CA2490200A1 (en) | 2' and 3'-nucleoside prodrugs for treating flaviviridae infections | |
| WO2006039488A3 (en) | Hcv ns3-ns4a protease inhibition | |
| MY128463A (en) | 4' substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus | |
| WO2002100415A3 (en) | 4'-substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus | |
| MY144593A (en) | Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication | |
| JP2013521279A5 (https=) | ||
| JP2015517528A5 (https=) | ||
| RU2015114543A (ru) | Способы лечения гепатита с | |
| WO2002089780A3 (en) | Antiviral compounds | |
| JP2004131466A5 (https=) | ||
| WO2021055425A3 (en) | Functionalized heterocycles as antiviral agents | |
| UA91677C2 (ru) | Макроциклические соединения как ингибиторы вирусной репликации | |
| JP2006511538A5 (https=) | ||
| WO2001097824A3 (de) | Verwendung von phyllanthusbestandteilen zur behandlung oder prophylaxe von infekten durch flaviviridae |